InvestSMART

Australian Clinical Labs Limited (ASX: ACL) - Announcements

Current share price for ACL : $2.870 0.01 (0.35%)+

ASX company news and announcements for Australian Clinical Labs Limited (ACL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Clinical Labs Limited (ACL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Clinical Labs Limited (ACL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Clinical Labs Limited (ACL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$535 Ceasing to be a substantial holder 16 Oct 2026 4:56PM $2.860 $2.870 risen by 0.35%
$535 Becoming a substantial holder 15 Oct 2026 5:43PM $2.840 $2.870 risen by 1.06%
$535 Ceasing to be a substantial holder 12 Oct 2026 3:26PM $2.920 $2.870 fallen by 1.71%
$535 Correction to Notice of Meeting for 2026 AGM 12 Oct 2026 10:45AM $2.915 $2.870 fallen by 1.54%
$535 Becoming a substantial holder 9 Oct 2026 5:41PM $2.940 $2.870 fallen by 2.38%
$535 Change of Auditor 2 Oct 2026 3:54PM $2.790 $2.870 risen by 2.87%
$535 Appendix 4G 22 Sep 2026 8:16AM $2.920 $2.870 fallen by 1.71%
$535 2026 Annual Report 22 Sep 2026 8:16AM $2.920 $2.870 fallen by 1.71%
$535 Notice of meeting - 2026 AGM 22 Sep 2026 8:15AM $2.920 $2.870 fallen by 1.71%
$535 Change in substantial holding 18 Sep 2026 4:17PM $2.880 $2.870 fallen by 0.35%
$535 Change of Director's Interest Notice - S Butler 14 Sep 2026 2:59PM $2.730 $2.870 risen by 5.13%
$535 Initial Director's Interest Notice - G Horan 31 Aug 2026 6:04PM $2.780 $2.870 risen by 3.24%
$535 Final Director's Interest Notice - M McGrath 31 Aug 2026 6:01PM $2.780 $2.870 risen by 3.24%
$535 Notification regarding unquoted securities - ACL 31 Aug 2026 12:31PM $2.790 $2.870 risen by 2.87%
$535 Notification regarding unquoted securities - ACL 31 Aug 2026 12:18PM $2.785 $2.870 risen by 3.05%
$535 Notification of cessation of securities - ACL 31 Aug 2026 12:12PM $2.785 $2.870 risen by 3.05%
$535 Ceasing to be a substantial holder 24 Aug 2026 4:42PM $2.990 $2.870 fallen by 4.01%
$535 Change in substantial holding from MUFG 21 Aug 2026 6:08PM $2.960 $2.870 fallen by 3.04%
$535 Change in substantial holding 20 Aug 2026 5:48PM $2.890 $2.870 fallen by 0.69%
$535 Ceasing to be a substantial holder 19 Aug 2026 3:17PM $2.825 $2.870 risen by 1.59%
$535 Dividend/Distribution - ACL 17 Aug 2026 8:12AM $2.350 $2.870 risen by 22.13%
$535 FY26 financial results investor presentation 17 Aug 2026 8:08AM $2.350 $2.870 risen by 22.13%
$535 Appendix 4E and FY26 financial reports 17 Aug 2026 8:08AM $2.350 $2.870 risen by 22.13%
$535 FY26 Results Investor Webinar 10 Aug 2026 4:03PM $2.350 $2.870 risen by 22.13%
$535 Date of 2026 AGM 10 Aug 2026 1:34PM $2.345 $2.870 risen by 22.39%

1 - 25 of 1028 results

Page 1 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.